JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

C5813 CFI-400945

Summary: orally available, selective inhibitor of polo-like kinase 4 (PLK4)

insoluble in H2O; ≥109.8 mg/mL
B1114 T 705

Target: RNA Polymerases

Summary: Potent and selective RNA-dependent RNA polymerase inhibitor

≥2.9 mg/mL
B1133 Tarafenacin D-tartrate

Summary: Highly selective M3 muscarinic receptor antagonist

Soluble in DMSO
B1256 AZ505 ditrifluoroacetate

Summary: SMYD2 inhibitor

insoluble in H2O; ≥119.8 mg/mL
B2157 Cabazitaxel
3 Citation

Target: Microtubule/Tubulin

Summary: Microtubule associated inhibitor

≥22.3 mg/mL
B1553 Tripelennamine HCl

Summary: H1-receptor antagonist

≥86.4 mg/mL
B2279 Oxcarbazepine

Summary: BTX inhibitor

insoluble in H2O; insoluble in EtOH; ≥9.1 mg/mL
B2028 Sodium salicylate

Summary: NF-κB inhibitor
B1178 Nafamostat hydrochloride

Summary: Synthetic serine protease inhibitor

Soluble in DMSO
B1062 Prazosin

Summary: alpha-adrenergic blocker

≥15.4 mg/mL